| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |